NCT04690660 · RECRUITING

Swiss Postpartum Hypertension Cohort

This Swiss registry follows women who have high blood pressure after giving birth. Researchers collect blood pressure readings, heart and kidney blood markers, and patient-reported outcomes to see how the condition unfolds over time. It is observational, so nobody is given a new treatment. No phase applies. It looks at current care, not a new therapy.

You may qualify if

  • all women with hypertensive disorders of pregnancy
  • postpartum hypertension (blood pressure measurements of systolic ≥140 and/or diastolic ≥ 90mmHg or antihypertensive therapy within the first 14 days after delivery)
  • women with preexisting hypertension or
  • women on antihypertensive medication

You're excluded if

  • delivery > 14 days
  • lack of consent to participate in the study, language barriers or lack of general understanding

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-05-28

View full record on ClinicalTrials.gov

All APOE4 clinical trials